Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

3.98
Delayed Data
As of Aug 22
 -0.12 / -2.93%
Today’s Change
2.06
Today|||52-Week Range
5.18
+56.69%
Year-to-Date
No recent news for Brainstorm Cell Therapuetics Inc.

Today’s Trading

Previous close4.10
Today’s open4.09
Day’s range3.84 - 4.11
Volume196,612
Average volume (3 months)119,277
Market cap$76.9M
Dividend yield--
Data as of 08/22/2017

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)-114.81%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book7.74

Competitors

 Today’s
change
Today’s
% change
PBMDPrima BioMed Ltd0.000.00%
AEZSAEterna Zentaris Inc-0.01-0.52%
HTGMHTG Molecular Diagno...-0.04-1.97%
PRTOProteon Therapeutics...+0.05+3.85%
Data as of 08/22/2017

Financials

Last reporting dateAugust 14, 2017
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$0.00
Annual profit (last year)-$5.0M
Net profit margin--

Profile

Sector
Electronic Technology
Industry
Computer Peripherals
President &
Chief Executive Officer
Chaim Lebovits
Chief Operating &
Medical Officer
Ralph Z. Kern
Corporate headquarters
Hackensack, New Jersey

Forecasts